LipoCoat
Enschede
About LipoCoat
LipoCoat is a biotech spin-off from the University of Twente. The company has developed a coating technology which improves the safety and comfort of medical devices without using antibiotics or toxic substances. The LipoCoat® coatings are developed for medical devices, such as contact lenses, catheters and implants. The coating is bio-inspired, hydrophilic, anti-fouling, multi-purpose and sustainable. In the past 3 years, LipoCoat has won 15 awards, competitions and grants.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $4.3M
- Funding stage: Early Stage Venture
- Last round: Series A (Apr 2020)
- Website: lipocoat.com
- Phone: +3153 - 82 00 816
Industries & Categories
Biotechnology, Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/lipocoat-121297 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.